BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 22729185)

  • 1. Ceramide function in the brain: when a slight tilt is enough.
    Mencarelli C; Martinez-Martinez P
    Cell Mol Life Sci; 2013 Jan; 70(2):181-203. PubMed ID: 22729185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids: membrane microdomains in brain development, function and neurological diseases.
    Olsen ASB; Færgeman NJ
    Open Biol; 2017 May; 7(5):. PubMed ID: 28566300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid metabolites in neural signalling and function.
    Colombaioni L; Garcia-Gil M
    Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
    Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
    Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of sphingolipids in selected cardiovascular diseases].
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
    Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
    Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and complexity of ceramide signalling in apoptosis.
    Okazaki T; Kondo T; Kitano T; Tashima M
    Cell Signal; 1998 Nov; 10(10):685-92. PubMed ID: 9884019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the signal transduction of ceramide and related sphingolipids.
    Liu G; Kleine L; Hébert RL
    Crit Rev Clin Lab Sci; 1999 Dec; 36(6):511-73. PubMed ID: 10656539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
    Ayub M; Jin HK; Bae JS
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids related to apoptosis from the point of view of membrane structure and topology.
    van Blitterswijk WJ; van der Luit AH; Caan W; Verheij M; Borst J
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):819-24. PubMed ID: 11709081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
    Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
    J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
    Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
    Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipids in mitochondria.
    Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Lipidomics Atlas of Selected Sphingolipids in Multiple Mouse Nervous System Regions.
    Wang C; Palavicini JP; Han X
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.